Characterization of TIMP-3 in human articular talar cartilage

Connective Tissue Research

Volumn 51, Issue 6, 2010, Pages 478-490

  Morris, Kirsten J ^a   Cs Szabo, Gabriella ^a   Cole, Ada A ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cartilage; Extracellular matrix; Glycosaminoglycans; Perlecan; Syndecan; TIMP 3

Indexed keywords

CHONDROITIN SULFATE; CYTOKINE; HEPARAN SULFATE; HEPARIN; INTERLEUKIN 1BETA; MESSENGER RNA; OSTEOGENIC PROTEIN 1; PROTEOHEPARAN SULFATE; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANKLE; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CARTILAGE DEGENERATION; CARTILAGE MATRIX; CELL COMPARTMENTALIZATION; DRUG BINDING; ENZYME LOCALIZATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN TISSUE; KNEE; KNEE OSTEOARTHRITIS; TALUS;

ADULT; CARTILAGE, ARTICULAR; CHONDROCYTES; EXTRACELLULAR MATRIX; HUMANS; SUBTALAR JOINT; TALUS; TISSUE INHIBITOR OF METALLOPROTEINASE-3;

EID: 78049442429     PISSN: 03008207     EISSN: 16078438     Source Type: Journal    
DOI: 10.3109/03008201003686958     Document Type: Article

References (39)

1. Nagase, H., and Woessner, J.F. (1999). Matrix metallopro-teinases. J. Biol. Chem. 274(31):21491-21494.
2. Apte, S.S., Olsen, B.R., and Murphy, G. (1995). The gene structure of tissue inhibitor of metalloproteinases (TIMP)-3 and its inhibitory activities define the distinct TIMP gene family. J. Biol. Chem. 270(24):14313-14318.
3. Williamson, A.R., Marston, F.A., Angal, S., Koklitis, P., Panico, M., Morris, H.R., Carne, A.F., Smith, B.J., Harris, T.J., and Freedman, R.B. (1999). Disulphide bond assign-ment in human tissue inhibitor of metalloproteinases (TIMP). Biochem. J. 268(2):267-274.
4. Brew, K., Deendayal, D., and Nagase, H. (2000). Tissue inhibitors of metalloproteinases: Evolution, structure and function. Biochem. Biophys. Acta 1477:267-283.
5. Woessner, J.F. (2001). That impish TIMP: The tissue inhibitor of metalloproteinase-3. J. Clin. Invest. 108(6):799-800.
6. Lee, M.H., Atkinson, S., and Murphy, G. (2007). Identifica-tion of the extracellular matrix (ECM) binding motifs of tis-sue inhibitor of metalloproteinases (TIMP)-3 and effective transfer to TIMP-1. J. Biol. Chem. 282(9):6887-6898.
7. Blenis, J., and Hawkes, S.P. (1884). Characterization of a trans-formation-sensitive protein in the extracellular matrix of chicken embryo fibroblasts. J. Biol. Chem. 259(18):11563-11570.
8. Blenis, J., and Hawkes, S.P. (1983). Transformation-sensitive protein associated with the cell substratum of chicken embryo fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 80(3):770-774.
9. Pavloff, N., Staskus, P.W., Kishnani, N.S., and Hawkes, S.P. (1992). A new member of metalloproteinase from chicken: ChIMP-3. J. Biol. Chem. 267(24):17321-17326.
10. Yu, W., Yu, S.C., Meng, Q., Brew, K., and Woessner, J.F. (2000). TIMP-3 binds to sulfated glycosaminoglycans of the extracellular matrix. J. Biol. Chem. 275(40):31226-31232.
11. Wilde, C.G., Hawkins, P.R., Coleman, R.T., Levine, W.B., Delegeane, A.M., Okamoto, P.M., Ito, L.Y., Scott, R.W., and Seilhamer, J.J. (1994). Cloning and characterization of human tissue inhibitor of metalloproteinase-3. DNA Cell Biol. 13(7):711-718.
12. De Ceuninck, F., Allain, F., Caliez, A., Spik, G., and Vanhoutte, P.M. (2003). High binding capacity of cylcophi-lin B to chondrocyte heparin sulfate proteoglycans and its release from the cell surface by matrix metalloproteinase. Arthritis Rheum. 48(8):2197-2206.
13. Govindraj, P., West, L., Koob, T.J., Neame, P., Doege, K., and Hassell, J.R. (2002). Isolation and identification of the major heparan sulfate proteoglycans in the developing bovine rib growth plate. J. Biol. Chem. 277(22):19461-19469.
14. Kevorkian, L., Young, D.A., Darrah, C., Donell, S.T., Shepstone, L., Porter, S., Brockbank, S.M., Edwards, D.R., Parker, A.E., and Clark, I.M. (2004). Expression profiling of metalloproteinases and their inhibitors in cartilage. Arthritis Rheum. 50(1):131-141.
15. Wantanabe, H., Wada, H., Itoh, M., Kataoka, M., Kido, H., and Naruse, T. (2002). Effect of heparinoid on the produc-tion of tissue inhibitor of metalloproteinase (TIMP-3) in rheumatoid synovial fibroblasts. J. Pharm. Pharmacol. 54(5):699-705.
16. Wang, L., Amqvist, K.F., Veys, E.M., and Verbruggen, G. (2002). Control of extracellular matrix homeostasis of normal cartilage by a TGF-β autocrine pathway. Validation of flow cytometry as a tool to study chondrocyte metabolism in vitro. Osteoarthr. Cartil. 10(3):188-198.
17. Su, S., DiBattista, J.A., Sun, Y., Li, W.Q., and Zafarullah, M. (1998). Up-regulation of tissue inhibitor of metallopro-teinase-3 gene expression by TGF-B in articular chondro-cytes is mediated by serine/threonine and tyrosine kinases. J. Cell. Biochem. 70:517-527.
18. Su, S., Grover, J., Roughley, P.J., DiBattista, J.A., Martel-Pelle-tier, J., Pelletier, J.P., and Zafarullah, M. (1999). Expression of the tissue inhibitor of metalloproteinases (TIMP) gene family in normal and osteoarthritic joints. Rheumatol Int. 18:183-191.
19. Kashiwagi, M., Tortella, M., Nagase, H., and Brew, K. (2001). TIMP-3 is a potent inhibitor of aggrecanse 1 (ADAM-TS4) and aggrecanse 2 (ADAM-TS5). J. Biol. Chem. 276(16):12501-12504.
20. Amour, A., Slocombe, P.M., Webster, A., Butler, M., Knight, C.G., Smith, B.J., Stephens, P.E., Shelley, C., Hutton, M., Knäuper, V., Docherty, A.J., and Murphy, G. (1998). TNF-α converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett. 435:39-44.
21. Borland, G., Murphy, G., and Ager, A. (1999). Tissue inhib-itor of metalloproteinase-3 inhibits shedding of L-selectin from leukoctyes. J. Biol. Chem. 274(5):2810-2815.
22. Hargreaves, P.G., Wang, F., Antcliff, J., Murphy, G., Lawry, J., Russell, R.G., and Croucher, P.I. (1998). Human myeloma cells shed the interleukin-6 receptor: Inhibition by tissue inhibitor of metalloproteinase-3 and hydroxamate-based metallopro-teinase inhibitor. Br. J. Haematol. 101(4):694-702.
23. Fitzgerald, M.L., Wang, Z., Park, P.W., Murphy, G., and Bernfield, M. (2000). Shedding of Syndecan-1 and-4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3 sensitive metalloproteinase. J. Cell Biol. 148(4):811-824.
24. Spurbeck, W.W., Ng, C., Strom, T.S., Vanin, E.F., and Davidoff, A.M. (2002). Enforced expression of tissue inhibitor of matrix metalloproteinase-3 affects functional capillary morphogenesis and inhibits tumor growth in a murine tumor model. Blood 100(9):3361-3368.
25. Muehlman, C., Bareither, D., Huch, K., Cole, A.A., and Kuettner, K.E. (1997). Prevalence of degenerative morpho-logical changes in the joints of the lower extremity. Osteoarthr. Cartil. 1:23-27.
26. Eger, W., Schumacher, B.L., Mollenhauer, J., Kuettner, K.E., and Cole, A.A. (2002). Human knee and ankle cartilage explants; catabolic differences. J. Orthop. Res. 20:526-534.
27. Rosenberg, L. (1971). Chemical basis for the histological use of safranin O in the study of articular cartilage. J. Bone Joint Surg. 53-A(1):69-82.
28. Mok, S.S., Masuda, K., Hauselmann, H.J., Aydelotte, M.B., and Thonar, E.J. (1994). Aggrecan synthesized by mature bovine chondrocytes suspended in alginate. Identification of two distinct metabolic matrix pools. J. Biol. Chem. 269(52):33021-33027.
29. Pfaffl, M.W. (2001). A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29(9):e45.
30. Jandik, K., Gu, K., and Linhardt, R. (1994). Action pattern of polysaccharide lyases on glycosaminoglycans. Glycobiology 4(3):289-296.
31. Ludowieg, J., Vennesland, B., and Dorfman, A. (1961). The mechanism of action of hyaluronidase. J. Biol. Chem. 236(2):333-339.
32. Anand-Apte, B., Pepper, M.S., Voest, E., Montesano, R., Olsen, B., Murphy, G., Apte, S.S., and Zetter, B. (1997). Inhibition of angiogenesis by tissue inhibitor of metalloprotein-ase-3. Invest. Ophthalmol Vis. Sci. 38(5):817-823.
33. Gomes, R., Kirn-Safran, C., Farah-Carson, M.C., and Carson, D.D. (2002). Perlecan: An important component of the carti-lage pericellular matrix. J. Musculoskelet. Neuronal Interact. 2(6): 511-516.
34. Wick, M., Burger, C., Brusselbach, S., Lucibello, F.C., and Muller, R. (1994). A novel member of human tissue inhibitor of metaloproteinases (TIMP) gene family is regulated during G1 progression, mitogenic stimulation, differentiation, and senescence. J. Biol. Chem. 269(29):18953-18960.
35. Postlethwaite, A.E., Raghow, R., Stricklin, G., Ballou, L., and Sampath, T.K. (1994). Osteogenic protein-1, a bone morphogenic proein member of the TGF-beta superfamily, shares chemotactic but not fibrogenic properties with TGF-beta. J. Cell Physiol. 161(3):562-570.
36. Mort, J.S., and Billington, C.J. (2001). Articular cartilage and changes in arthritis matrix degradation. Arthritis Res. 3:337-341.
37. Davidson, R.K., Waters, J.G., Kevorkian, L., Darrah, C., Cooper, A., Donell, S.T., and Clark, I.M. (2006). Expression profiling of metalloproteinases and their inhibitors in syn-ovium and cartilage. Arthritis Res. Ther. 8(4):124-134.
38. -/- mice. Arthritis Rheum. 56(3):905-909.
39. Gendron, C., Kashiwagi, M., Hughes, C., Caterson, B., and Nagase, H. (2003). TIMP-3 inhibits aggrecanse-mediated glycosaminoglycan release from cartilage explants stimulated by catabolic factors. FEBS Lett. 555(13):431-436.